UnityPhilly Response App for Overdose Reversal

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDrexel University

About this trial

The goal of this clinical trial is to discover if an overdose prevention app (UnityPhilly) can encourage citizen responders to respond and prevent opioid overdoses using the UnityPhilly app. The main hypotheses to answer are:

Hypothesis 1: UnityPhilly signal rates relative to EMS calls will increase over time. The primary outcome will be assessed as the total number of overdoses signaled by participants relative to all overdose-related EMS calls, per year.

Hypothesis 2: The number of cases where a nearby UnityPhilly participant successfully reverses an overdose with naloxone will increase over time. The primary outcome will be assessed as the number of successful reversals relative to the total number of responder arrivals, per year.

Participants will be supplied with the UnityPhilly app, training on how to use the app and respond to an opioid overdose using naloxone, and respond to follow up surveys about their experiences.

Eligibility criteria

Qualifiers

owning a smartphone with a data package;

living or working in one of three identified Philadelphia neighborhoods;

aged 18 or older.

Disqualifiers

persons aged under 18 years of age

Trial design

Treatments tested in this trial

  • UnityPhilly app

Treatment groups

450 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Drexel University

Lead sponsor

University of Michigan

Collaborator